| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |